260 results on '"Niitsu, N"'
Search Results
2. CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab
3. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma
4. A clinicopathological study of nm23-H1 expression in classical Hodgkin’s lymphoma
5. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations
6. Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma
7. Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature
8. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma
9. Simulation of Nuclear Dynamics of C60: From Vibrational Excitation by Near-IR Femtosecond Laser Pulses to Subsequent Nanosecond Rearrangement and Fragmentation
10. Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study
11. Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study
12. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma
13. Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13)
14. Human herpes virus-8 associated with two cases of primary-effusion lymphoma
15. A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin’s lymphoma
16. Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkin's lymphoma
17. THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin’s lymphoma in elderly patients: a prospective study
18. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma
19. Serum soluble Interleukin-2 receptor (sIL-2R) levels in diffuse large B-cell lymphoma (DLBCL): A significant prognostic factor.
20. Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy
21. Upper GI examinations in older premature infants with persistent apnea: correlation with simultaneous cardiorespiratory monitoring
22. Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan
23. Interaction between Transferrin and Tumor Cell Receptor
24. A Multicenter Phase II Study of Bendamustine with Rituximab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
25. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type
26. Retrospective analysis of CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) treated with chemotherapy with or without rituximab
27. Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy
28. Increment of the number of aberrant crypt foci in ulcerative colitis patients
29. Increased population of Th2 like cells with a phenotype of CD45RO+CD62L+In patients with ulcerative collits
30. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96
31. COP‐BLAM regimen combined with granulocyte colony‐stimulating factor and high‐grade non‐Hodgkin's lymphoma
32. Cardiotoxicity of combined chemotherapy in patients with hematopoletic malignancles — Use of 123I-MIBG myocardial SPECT
33. Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.
34. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.
35. Non-Hodgkin's Lymphoma in the Elderly: A Guide to Drug Treatment.
36. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma
37. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs
38. A case of partial trisomy 3q
39. First-principles simulation of the control of vibrational and fragmentation dynamics of C60 by intense near-infrared pulses.
40. Theoretical study of the dynamical behaviors of molecules and living cells in laser fields.
41. Robust, high-performance n-type organic semiconductors.
42. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
43. Charge mobility calculation of organic semiconductors without use of experimental single-crystal data.
44. Capturing the photo-induced dynamics of nano-molecules by X-ray free electron laser induced Coulomb explosion.
45. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
46. NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells.
47. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
48. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
49. Communication: Two-step explosion processes of highly charged fullerene cations C60(q+) (q = 20-60).
50. [Targeted therapy].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.